Search & Analyze
Popular Searches
Invicta Diagnostic Ltd.
Healthcare₹67.00
CMP₹67.00
Mkt Cap₹84 Cr
P/E17.17
P/B1.64
ROE40.48%
52W High₹0.00
52W Low₹0.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
17.17
P/B Ratio
1.64
EV/EBITDA
8.19
Price/Sales
2.60
Dividend Yield (%)
0.00
EPS (TTM ₹)
3.90
Book Value (₹)
40.89
ROE (%)
40.48
ROCE (%)
42.85
ROA (%)
26.57
EBITDA Margin (%)
30.57
Net Profit Margin (%)
16.38
Debt/Equity
0.24
Current Ratio
2.37
Interest Coverage
29.51
Asset Turnover
1.62
Working Capital/Sales
8.16
Core EBITDA Growth (%)
29.78
P&L
| Particulars | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|
| Gross Sales | 1583.05 | 3009.52 |
| Net Sales | 1583.05 | 3009.52 |
| Total Income | 1589.82 | 3018.13 |
| Total Expenditure | 874.37 | 2089.63 |
| Operating Profit | 715.45 | 928.5 |
| Depreciation | 193.28 | 249.12 |
| Exceptional Items | — | — |
| Profit Before Tax | 512.09 | 656.36 |
| Tax | 131.55 | 163.41 |
| Profit After Tax (PAT) | 380.54 | 492.95 |
| EPS (₹) | 4.52 | 5.86 |
| Dividend Payout % | — | — |
Balance Sheet
| Particulars | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|
| Share Capital | 13.15 | 841.79 |
| Reserves | 960.17 | 620.68 |
| Shareholders Funds | 973.32 | 1462.47 |
| Total Debt | 381.14 | 353.84 |
| Total Liabilities | 1588.72 | 2121.65 |
| Total Assets | 1588.72 | 2121.65 |
| Book Value / Share | 740.1673 | 17.3733 |
| Assets | 1588.72 | 2121.65 |
Cash Flows
| Particulars | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|
| Operating Activities | 636.16 | 655.86 |
| Investing Activities | -859.75 | -522.97 |
| Financing Activities | 352.76 | -50.32 |
| Net Cash Flow | 129.17 | 82.57 |
INVICTA
₹67.00
+0%